U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry EPIMERIC
Molecular Formula C62H105N12O30P
Molecular Weight 1529.5333
Optical Activity UNSPECIFIED
Defined Stereocenters 19 / 20
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Ozisiran 3'-adenosine modification

SMILES

CO[C@@H]1[C@H](OP(O)(=O)OCC(O)C(=O)N(CCCNC(=O)CCCCO[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2NC(C)=O)CCCN(CCCNC(=O)CCCCO[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3NC(C)=O)C(=O)CCCCO[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4NC(C)=O)[C@@H](CO)O[C@H]1N5C=NC6=C5N=CN=C6N

InChI

InChIKey=YQRNSCIPXMGCDT-SAUWULSOSA-N
InChI=1S/C62H105N12O30P/c1-33(79)69-44-51(89)48(86)37(26-75)101-60(44)96-23-8-5-14-41(83)64-17-11-19-72(43(85)16-7-10-25-98-62-46(71-35(3)81)53(91)50(88)39(28-77)103-62)21-13-22-73(20-12-18-65-42(84)15-6-9-24-97-61-45(70-34(2)80)52(90)49(87)38(27-76)102-61)58(92)36(82)30-99-105(93,94)104-54-40(29-78)100-59(55(54)95-4)74-32-68-47-56(63)66-31-67-57(47)74/h31-32,36-40,44-46,48-55,59-62,75-78,82,86-91H,5-30H2,1-4H3,(H,64,83)(H,65,84)(H,69,79)(H,70,80)(H,71,81)(H,93,94)(H2,63,66,67)/t36?,37-,38-,39-,40-,44-,45-,46-,48+,49+,50+,51-,52-,53-,54-,55-,59-,60-,61-,62-/m1/s1

HIDE SMILES / InChI

Approval Year

Name Type Language
Ozisiran 3'-adenosine modification
Common Name English
(2RS)-3-(1,23-bis[(2-acetamido-2-deoxy-?-Dgalactopyranosyl)oxy]-14-{5-[(2-acetamido-2-deoxy-?-D-galactopyranosyl)oxy]pentanoyl}-5,19-dioxo-6,10,14,18-tetraazatricosan-10-yl)-2-hydroxy-3-oxopropyl hydrogen 2'-O-methyl adenosine phosphate
Preferred Name English
Code System Code Type Description
FDA UNII
FX4KH7KJ4V
Created by admin on Wed Apr 02 19:17:15 GMT 2025 , Edited by admin on Wed Apr 02 19:17:15 GMT 2025
PRIMARY